Global Vitamin K2 market is projected to reach $1,160.78 million by 2030, with CAGR of 29.7%

From GlobeNewswire: 2025-03-20 07:56:00

The global Vitamin K2 market is projected to reach $1,160.78 million by 2030, growing at a CAGR of 29.7%. Key players include Lonza Group AG, International Flavors & Fragrances Inc, and BASF SE. Trends include synthetic MK-4 products and innovations in vitamin K2 tablets. North America led the market in 2023.

The rising demand for Vitamin K2 is driven by its role in preventing CVDs and osteoporosis. Vitamin K2 supports heart health, bone metabolism, and brain function. Gnosis by Lesaffre launched MenaQ7 Natural in MCT Oil. Kappa Bioscience introduced organic-grade vitamin K2-MK7. DSM is in negotiations to acquire Adare Biome for $301.2 million.

The market is segmented by product (MK-4, MK-7, combination drugs), dosage forms (capsules, tablets, powder, oils), source (natural, synthetic), and application (pharmaceuticals, nutraceuticals, food). Asia Pacific is expected to have the highest CAGR. The report offers insights for pharmaceutical companies, hospitals, and consumers.

For more information on the Vitamin K2 market, visit: https://www.theinsightpartners.com/reports/vitamin-k2-market. Contact Ankit Mathur at [email protected] or +1-646-491-9876 for inquiries or further information. Press release available at: https://www.theinsightpartners.com/pr/vitamin-k2-market.



Read more at GlobeNewswire: Vitamin K2 Market to Reach US$ 1,160.78 Million by 2030,